BIOCHEMICAL
Vol. 104, No. 3, 1982 February 11, 1982
INHIBITION
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS Pages 957-964
OF THE SOLUBLE GUANYLATC CYCLASE FROM RAT LUNG BY SULFATED POLYANIONS Marcia
A. Liebel
and Arnold
A. White
Department of Biochemistry and the John M. Dalton University of Missouri-Columbia, Columbia, Received
December
22,
Research Center, MO 65217
1981
SUMMARY: Soluble guanylate cyclase was partially purified from rat lung homogenates, and shown to be inhibited by the following sulfated polyanions, in ,,g/ml in parentheses: Polyvinyl sulfate (0.33), 40,000-dalton ate (0.45), polyanetholesulfonate (0.63) 500,000-dalton dextran sulfate (1.8), x-carrageenan (2.9), t-carrageenan (6.1), K-Carrageenan (48.0), heparin (68.0). There was a good correlation between inhibitory potency and sulfate content (as total sulfur). Inhibision by hepariy +and thy+carrageenay$ or !$g (but not the othersj+was potentiated by Mn , but not Ca when [Mn exceeded [GTP]. Mn -potentiation could be blocked by high Na . ieparinagarose shows promise as an affinity matrix for guanylate cyclase. A large
number
of enzymes
have been shown
lytes
(1)
and most of these
by polyanions
showed
that
certain
polyanions,
synthetic
the thyrotropin-stimulated brane.
Salomon
in detail
the effects
clase,
and found
that
inhibitors.
In the
inhibitors
of guanylate
polyanions
differ
excess
Mn2+.
of guanylate MATERIALS
cyclase
(5-7)
extended
We also cyclase
these
the
glycosaminoglycans
report
cyclase
[EC 4*6*1*2];
the synthetic include using
that
ones
preliminary
data
sulfate,
thyroid
inhibited
plasma
observations
mem-
by examining
upon adenylate were
sulfated
however in their
and Cook (4)
dextran
polyanions
we showed
by polyelectro-
Wolff
of bovine
occurring
sulfated
3).
including
of naturally
present
from
(2,
adenylate
and coworkers
to be inhibited
the
the most
potent
polyanions
are
naturally
inhibitory
on the affinity
cy-
also
occurring
response
to
chromatography
heparin-agarose.
AND METHODS
The commercial sources of chemicals used in guanylate cyclase tion and assay have been previously given (10, 11). Heparin-agarose plied by Bethesda Research laboratories, and contained 0.84 mg of heparin per ml of gel. Sigma supplied all of the polyanions except arin (l\la+, 100 unitslmg) which was from Nutritional Biochemicals, polyanetholesulfonate (Liquoid), which was provided by Hoffman-La
957
purificawas supcouplied for hepand sodium Roche.
0006-291X/82/030957-08$01.00/0 Cop.vrighi 0 1982 b-vAcademic Press, Inc. ,411nghrs of reproduction in any form reserved.
]
Vol. 104, No. 3, 1982
BIOCHEMICAL
AND BIOPHYSICAL
POLYANION
d ? 5 0
RESEARCH COMMUNICATIONS
(ugl
706050-
k
40-
5 $
30-
5 a
20 IO i
POLYANION Fi ure 1. Inhibition !a: determined with is shown the effect dextran sulfate (A), (0). In B is shown polyanetholesulfonate
(fig)
of guanylate cyclase by sulfated polyanions. Activity and the indicated amount of polyanion. In A 3 mM MnCls,, of hyalur nlc acid ,lJ), heparin (0), 500,000 dalton40,000-dalton dextran sulfate (A), and polyvinyl sulfate the effect of K(O), I(@) and x-carrageenan (I), (A), and again, heparin (0).
Guanylate cyclase purification. (8) purification procedure, filtration and DEAE-cellulose phenylmethylsulfonyl fluoride a 2.6x80 cm Ultragel AcA 34 column was eluted in 1.8 ml 155. The activity peak from
The only change in the previously described (NH ) SO4 precipitation, gel which involved inclusion of (DE 52) chromate 8sr phy was the in the homogenizing medium (50 ug/ml), and that This column was used for the gel filtration step. fractions and activity appeared in fraction 125the DE 52 column was concentrated by precipita-
958
Vol.
104,
No.
3, 1982
TABLE
I:
Correlation
BIOCHEMICAL
between
AND
inhibitory
BIOPHYSICAL
potency
and
RESEARCH
total
sulfur
content Total
I50 Polyanion
(ughl
Polyvinyl
sulfate
Dextran
sulfate
(40,000-dalton)
Polyanetholesulfonate Dextran
sulfate
(500,000-dalton)
COMMUNICATIONS
)
of
poiyaniOnS
S
(%I
0.33
16.7+0.4-
0.45
16.8tO.3
0.63
11.3+0.2-
1.8
15.750.3
A-Carrageenan
2.9
11.Ci+o.2 -
I-Carrageenan
6.1
9.1+0.3 -
K-Carrageenan
48.0
6.7tO.3
Heparin
68.0
7.4+0.5 -
tion with (NH ) SO at 50% of saturation, the precipitate redissolved in 8 ml of 5 mM Tris-fiC?, 8 H 7.6, 15 mM Z-mercaptoethanol and dialyzed 10 hr against 4 1 of this solution. After a second dialysis against 4 1 of 0.5 mM EDTA (Tris), pH 7.6, containing 2.5 mM dithioerythritol, glycerol was added to a concentration of 10:: and the solution stored in 0.5 ml aliquots at -30". Enzyme determination and other methods. Guanylate cyclase activity was determined as previously described (9), using siliconized reaction tubes, 1.2 to unless a different concentration is 1.4 ug of enzyme protein and 3 mM MnCl All determinations were in tri $'. locate, and the Imean + S.E. are renoted. ported. The figures have bars representing the S.E., except-where this was Protein was determined by the method of Bradford smaller than the symbol. Total sulfur content of the using bovine plasma albumin as standard. (lo), polyanions was determined by prompt y-ray neutron activation analysis (11). RESULTS: ronic
Dose-response acid
was
C (not
shown).
l),
Table
in
curves
not
I,
appreciably
The
inhibitors
with
their
anetholesulfonate, sulfate)
of
Inhibition Fig.
2 shows
only
76b
by that
by
2 ng
substitution
of
potentiation. diagrammed groups: and
2+
This in
Fig.
but
or
3,
carrageenans
Ca2+
which
for
show
Mn
(no
2+
rank
be
excess more
that 3A)
order
-potentiated, 959
Mn '+
2+ ),
HyaluA,
(from
Except
an
and
B or
Fig.
for
increase
activity
was
mM excess did
not
Mn
poly-
sulfur
(or
in
polyanions
Mn2+ -potentiated the
2+
in
.
However, a similar
the fell
(Fig. dextran
Mn2+
inhibited
produce
examined
sulfated
while
potency
potency
by
thoroughly the
and
7.2
1.
density.
increased
at
Fig.
content.
change
Mn
in
sulfate
of
between the
88%
shown
chondroitin
sulfur
excess
the was
(Fig. were
to
reached
phenomenon
Mn'+-independent the
found
mM MnGTP
was
correlation hence,
was
1.2
in
total
a good
are
nor
shown
polyanion,
heparin, Mg
are
heparin at
inhibitors
inhibitory,
was
the
the
determined
there
content
for
3B). sulfates,
studies into
two
Heparin poly-
.
Vol. 104, No. 3, 1982
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
30. z w k ; 25a
ol
a
0
12
2.4
3.6
EXCESS
4.8
60
72
METAL (mM)
Fiqure 2. Effect of Ca'+, Mg2+ and Mn*+ concentration on the inhibition of guanylate cyclase by heparin. Activity was dets$mined in t5$ presence of Jr2 mM MnGTP plus the indicated concentration of Ca &Al, Mg D,P , or Mn (o,.), in the absence (A,O,O) and presence (A,aO) of 2 pg heparin.
anetholesulfonate
and polyvinyl
obvious
difference
curring
while Wolff
between
M KCl,
examined
that
cyclase. by heparin,
Fig.
x-carrageenan
sulfate
more sensitive polyanions.
Reversal
are
naturally
by the
oc-
while
due to Cl - interference
dextran was eliminated,
to 16.5% from
the
Mn2+ -potentiated than may result
electrostatic 960
by
effect.
inhibition
We of
upon inhi-
sulfate. while 30.0% with polyanions
At 80 mM the
in-
no was much
the Mn2+ -independent from
of Mn2+ -independent
reversal with
in the
of the
reversed
of NaCl concentration
NaCl concentration
of Mn"-potentiation
sulfate
was partially
involved
two polyanions
was decreased
inhibition
site,
first
was due to a charge
and 500,000-dalton
first
to increasing
by Nat at a binding probably
that
The most
by dextran
in thyroid
4 shows the effect
by dextran appeared
cyclase
effect
hibition
the
inhibition
of a similar
by the
It
the
inhibition
inhibition
2+ -independent.
is that
the
NaCl the
salt.
that
adenylate
and concluded
Mn
synthetic.
showed
the possibility
guanylate bition
are
and Cook (4)
were
the two groups
the second
thyrotropin-stimulated 0.167
sulfate
binding.
replacement inhibition
of Mnzt is
Vol. 104, No. 3, 1982
BIOCHEMICAL
Figure 3. Effect of by sulfated polyanions. MnGTP plus the indicated no addition (O), and 0.12 pg 500,000-dalton sulfate (A) and 0.02 no addition (0), and (U), 0.1 Vg I-carrageenan
These
results
tography because
it
such
experiment,
with
buffer
taining vity,
readily
while
remaining
activity
was
40%,
the
loss
cular
of
activator
stimulation remains
from
be
these
the
was
polyanions
preliminary
studies
so
column
activity
is
(column
removed
A.
complet
ely
retained
from
recovery
activity due for
(12-14).
to some The
or
loss all
purification
determined. 961
one
equilibrated
buffer
not
with
the
B,
activity about
the
the
Increasing
column
on of
used,
B.
increased the
results
eluted
of
chroma-
shows
was
column
activity The
were other
from
the
IX
the
activity
affinity
heparin-agarose,
B),
detectable
M removed
with
co1 umns
columns
as
Table
heparin-agarose
specific
activity
of
commercially.
the
responsible of
to
0.25
and
total
done
Both
all
none
to
about
A).
nearly
concentration
use
8 mM MnC12
(column
M NaCl,
the
two
containing
however,
0.1
(4.
available
where
Mn*+
concentration on the inhibition of guanylate cyclase Activity was determ@ed in the presence of 1.2 mM concentration of Mn In A is shown the effect with in the presence of 0.04 ~9 polyanetholesulfonate (a), dextran sulfate (A), 0.02 ug 40,000-dalton dextran Pg polyvinyl sulfate (D). In B is shown the effect with in the presence of 2 ug of heparin (0) or K-carrageenan (A) and 0.07 ug A-carrageenan
We have
is
RESEARCH COMMUNICATIONS
Mn*+
suggested
ligands.
AND BIOPHYSICAL
columns
from
applied from
as
well
from 48%.
conacti-
column the
A by
NaCl as
the
one
the
columns
We believe of
the
that
macromole-
concentration-dependent attainable
on
these
columns
Vol. 104, No. 3, 1982
BIOCHEMICAL
O-3
0
AND BIOPHYSICAL
20
40 NaCl
RESEARCH COMMUNICATIONS
60 ktlM1
80
100
Figure 4. Effect of NaCl concentration on guanylate cyclase additional polyanion (Oj, and in the presence of 1 pg heparin 500,000-dalton dextran sulfate Q), or 0.05 ug A-carrageenan reactions contained 6 mM MnC12.
DISCUSSION:
Salomon
aminoglycans
and
adenylate
cyclase
sulfation,
rather
similar
usually
on
therefore
towards
both
guanylate
fate 16 the
we
of
of
synthetic
(7)
became
enzymes.
However,
make
inhibitor
of
it
cyclase B),
essentially
(15U=2 was no
of
Mg
of
adenylate
500,000-dalton
,,g/ml ,,g/ml)
on dextran
glycosovary
with
the
of
Mn
fAn
cyclase
heparin
at
3 mM Mn2*)
activity is
inhibition,
is
no and
as
guanylate
cyclase. had
weak
compared
Similarly, cyclase
it
potency a relatively
adenylate
sulfate
potentiate
, there
inhibitor
that
(6).
2+
to
guanylate
cyclase
than
of
to
of
come
on
2+
adenylate
rather
degree
We had polyanions
comparison
a potent effect
rat
correlate
ability
2+
no ug
sulfated of
sulfated
the
appears 68
the
with 0.15 The
polysaccharide.
the
a direct
(150=
sulfate
polyanion
to
Since
potentiation to
with
aware
of
inhibitors
the
of
presence
difficult
adenylate
of
effects
the
some
potent
polysaccharides.
in
(chrondroitin ug/ml,
the
that
appeared
structure the
a similar
cyclase
inhibition
the
about
determined
information is
than
some
were
Inhibition
until
by
showed
sulfate,
(5-7).
activity
inhibition
coworkers
dextran
conclusions
cyclase
is
and
activity (O), (A).
with
dermatan inhibitor, In similar
its sul-
15U= contrast, inhibitory
Vol. 104, No. 3, 1982
TABLE
II:
BIOCHEMICAL
Effect
of
MnCi,
on
Fraction number
AND BIOPHYSICAL
the
NaCl buffer CM)
binding
of
guanylate
cyclase
Guanylate (nmol cyclic
in
Column
Applied
0
36.7+0.2 (looTloo)
1
0
(0,LO)
2
0.1
53.0+0.2 (40.5,
3
RESEARCH COMMUNICATIONS
0.25
by
heparinagarose
cyclase activity GMP/min/mg protein) A
Column
B
34.5+2.2 (100;100)
28.0)
23.4+0.4 (6.2T9.8)
(0,
li.7)
(0,
l/).4)
52.6+9.0 (43.4, F8.4)
Two 0.7x2 cm heparin-agarose columns were equilibrated respectively with 50 mM Tris-HCl, pH 7.6, 15 mM P-mercaptoethanol (buffer A) and the same solution with 8 mM MnC12 (buffer B). To each column was applied 0.5 ml enzyme, followed by three 2 ml applications of buffer containing the indicated concentrations of NaCl. Activity of the applied enzyme, and in the collected fractions, was determined with 3.2 mM MnCl and 0.1 M NaCl. In parentheses are shown recoveries of activity and prote ? n, consecutively.
potency
for
adenylate
cyclase
(15D
= 1.8
electrostatic structure
cyclase
are
,,g/ml). while
involved.
The
ternate
B-D-galactose-4-sulfate
sulfate
residues X-ray
geenan
have
been
ever,
double
the
x-ray
data
helix.
The
the
inverse
fore, is
though
it
fraction has
helix
can patterns
shown
fects
in
high
degree
of
that circular of
their
in
terms
have
be
shown of
the to sodium
is
inhibited
potency may
have
helical
order
helical
blue
that
of
a random structure
salts
are
complexes which solution.
963
rank of
in
order,
A‘.l:'k
k-
r-carra-
and
How-
but
thus not
a double
(k>liX)
is
cyclase, the
coil
in
when
x-ray
extrinsic that
in
there-
enzyme.
solution
(17).
al-
additional
sulfation,
with
indicated
of
structure.
guanylate
display
of
largely
helices
recorded
to
aspects
structure double
only
with
increase
interaction
spectroscopy, in
an
form
of
calcium
the
a double
inhibitors
a helical
or
in
guanylate
due
consist
fibers
decrease
conformation
to
a helical
as
be
other
oriented
to
with
D-galactose, is
by
carrageenans
heparin-methylene dichroism
of
did
may
known
content of
it
polyanions
anhydro-
suggest
formation
to
3,6
as
inhibition
are
patterns
the
(7)
natural
sulfate
A-carrageenan of
order
considered
Their
formation
for
the
carrageenans
interpreted
ability
double
with
diffraction
helix
,g/ml)
sulfate
and
(15).
I).
= 4-6
Dextran
binding,
(Table
(ISO
Heparin (16),
fiber
al-
dif-
Stone Cotton heparin
(18) efhas
a
Vol. 104, No. 3, 1982 It quired
is
not
for
Mn
independent strong
2+
up the
potentiated (Table
imnediately
between random
inhibitors
I),
obvious
-potentiated
polyanions
repulsion
and open
BIOCHEMICAL
and therefore
tion
for
Mnzt-potentiation,
form
of a new affinity
AND BIOPHYSICAL why the
We are
inhibition. are
not
the coil
helical ionized
(19).
have a lower
groups
chromatography
conformation assuming
at these
ionic
would
that
charge
tend
hoping
density form
medium for
helices.
the
the Mn
that
the other Whatever
the
phenomenon
purification
be re2+
since
to stretch
than
to exploit
would
strengths,
It may not be coincidental
may more readily we are
helical
RESEARCH COMMUNICATIONS
the
the molecule the Mnztpolyanions the
explanain the
of guanylate
cyclase. to M.D. Glascock and T. Spaulding of the ACKNOWLEDGEMENTS: We are grateful for the determinations of total University of Missouri Research Reactor, This work was supported by Grant No. sulfur by neutron activation analysis. USPH 5 SO7 RR05387 awarded by the National Institutes of Health, Biomedical Research Support Grant Programs, and the John M. Dalton Research Center. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. E: 12. 13. 14. 15.
K: 18. 19.
Elbein, A D. (1974) in Advances in Enzymology (Meister, A., ed.) Vol. 40, pp. 29-61 Academic Press, New York. Bernfeld, P. (1963) in Metabolic Inhibitors (Hochster, R.M. and Quastel, J.H., eds ) Vol. 2, pp. 437-472, Academic Press, New York. Bernfeld, P. (1966) in The Amino Sugars (Balazs, E.A. and Jeanloz, R.W., eds.). vo ZB, pp. 213-228, Academic Press, New York. Wolff, J. and Cook, G.H. (1975) J. Biol. Chem. 250, 6897-6903. Salomon, Y. and Amsterdam, A. (1977) FEBS Lett. 83, 263-266. Salomon, Y., Amir, Y., Azulai, R. and Amsterdam, A. (1978) Biochim. Biophys. Acta 544, 262-272. Amsterdam, A., Reches, A. Amir, Y., Mintz, Y. and Sa lomon, Y. (1978) Biochim. Biophys. Acta 544, 273-283. White, A.A., and Karr, D.B. (1980) J. Cyclic Nucleo tide Res. 6, 221-282. White, A.A. and Karr, D.B. (1978) Anal. Biochem. 85, 451-460. Bradford, M.M. (1976) Anal. Biochem. 72, 248-254. Hanna, A.G., Brugger, R.M. and Glascock, M.D. (1981) Nucl. Instr. and Meth., in the press. Tsai, S.C., Manganiello, J.C. and Vaughan, M. (1978) J. Biol. Chem. 253, 8452-8453. Liebel , M.A., Rapp, N.S. and White, A.A. (1980) Biochim. Biophys. Acta 616, 310-318. Nakazawa, K. and Kitajima, S. (1980) Biochim. Biophys. Acta 612, 171-177. Rees, D.A. (1969) in Advances in Carbohydrate Chemistry and Biochemistry (Wolfram, M.L. and Tipson, R.S., eds.) Vol. 24, pp. 267-332, Academic Press, New York. Stivala, S.S. (1977) Fed. Proc. 36, 83-88. Atkins, E.D.T. and Nieduszynski, I.A. (1977) Fed. Proc. 36, 78-83. Stone, A.L. (1977) Fed. Proc. 36, 101-106. Katchalsky, A. (1964) Biophys. J. 4;Suppl., 9-41.
964